Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rand Corp.

This article was originally published in The Gray Sheet

Executive Summary

"Managed Care and the Evaluation and Adoption of Emerging Technology" study is scheduled for release March 21. The study is intended to provide tips on how medical device manufacturers prepare for device evaluation and coverage decisions by managed care organizations. Sponsors of the study include the California Goldstrike Partnership of the State of California's Trade and Commerce Agency, the Economic Development Administration of the U.S. Department of Commerce, and the Health Industry Manufacturers Association (1"The Gray Sheet" May 24, 1999, In Brief)

You may also be interested in...



HIMA technology adoption study

Rand Health is selected by the Health Industry Manufacturers Association to conduct a study on the adoption of new medical technology in managed care settings. Expected to be complete by late fall, the study will identify how managed care organizations currently review and pay for technology, and how device firms prepare for this process. The study "may reveal voluntary 'best practices' for introducing emerging technologies into the managed care environment," HIMA says

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013132

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel